Origin Therapeutics Holdings, Inc. (TSE:SPLY) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Safe Supply is set to acquire Drug Lab 118 Ltd.’s subsidiary, enhancing its medical testing portfolio with proprietary harm reduction test strips for the North American market. The deal involves the issuance of 10 million Safe Supply shares and the addition of a Drug Lab Parent nominee to Safe Supply’s board. This strategic move aims to capitalize on the growing market for narcotic testing and harm reduction solutions.
For further insights into TSE:SPLY stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money